Izotropic Corporation

C$0.12As of Sun 8 Nov 2026, 12:00 UTC
CSE:IZOHealthcare
Country Canada
PE (Fwd) •••
TSR 8Y CAGR (9.30%)
Div yield —
ROE —
Diagnostics & Research
Beta (5Y) 2.48
PE TTM —
TSR TTM (74.44%)
Mkt cap C$8.317M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.142
23.45%
2.68%
Hold 3|7|1|8|0
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
10.16%
19.75%
26.35%
19.30%
Revenue$M
0.598
0.602
0.594
0.589
(1.30%)
(2.24%)
(3.85%)
(4.42%)
Peers (US$5.887M)
Cap (US$)
PE
5.055M
—
Capital
TTM
5Y
10Y
Leveragex
2.932
(0.752)
(0.599)
EBIT/Intx
4.658
0.224
0.234
Own earn%
70.23
53.16
50.52
Sh yield%
45.76
28.14
27.84
Owners
Insiders/Inst%
8.27
20.44
Short interest%
3.96
SBC / revenue%
0.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
15–25
$1 testx
1.7
Incr. ROIC%
−3